Cardiovascular side effects of newer antidepressants

Antony Fernandez, Suji E. Bang, Komandur Srivathsan, W. Victor R. Vieweg

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)305-309
Number of pages5
JournalAnadolu Kardiyoloji Dergisi
Volume7
Issue number3
StatePublished - Sep 1 2007

Keywords

  • Antidepressant drugs
  • Atrial fibrillation
  • Blood pressure
  • Bradycardia
  • Cardiac death
  • Cardiovascular eftects
  • Electrocardiogram
  • Hypertension
  • Hypotension
  • QT interval
  • Tachycardia
  • Ventricular premature beats

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Cardiovascular side effects of newer antidepressants'. Together they form a unique fingerprint.

  • Cite this

    Fernandez, A., Bang, S. E., Srivathsan, K., & Vieweg, W. V. R. (2007). Cardiovascular side effects of newer antidepressants. Anadolu Kardiyoloji Dergisi, 7(3), 305-309.